138 related articles for article (PubMed ID: 3874027)
1. Defects in mononuclear phagocytic system (MPS) function in autoimmune MRL-lpr/lpr mice.
Jones FS; Pisetsky DS; Kurlander RJ
Clin Immunol Immunopathol; 1985 Jul; 36(1):30-9. PubMed ID: 3874027
[TBL] [Abstract][Full Text] [Related]
2. Mononuclear phagocyte system dysfunction in murine SLE: abnormal clearance kinetics precede clinical disease.
Meryhew NL; Shaver C; Messner RP; Runquist OA
J Lab Clin Med; 1991 Mar; 117(3):181-93. PubMed ID: 2002275
[TBL] [Abstract][Full Text] [Related]
3. Effects of castration and sex hormones on immune clearance and autoimmune disease in MRL/Mp-lpr/lpr and MRL/Mp-+/+ mice.
Shear HL; Wofsy D; Talal N
Clin Immunol Immunopathol; 1983 Mar; 26(3):361-9. PubMed ID: 6872348
[TBL] [Abstract][Full Text] [Related]
4. MRL mice show an age-related impairment of IgG aggregate removal from the circulation.
Field M; Brennan FM; Melsom RD; McCarthy D; Mumford P; Maini RN
Clin Exp Immunol; 1985 Jul; 61(1):195-202. PubMed ID: 4042418
[TBL] [Abstract][Full Text] [Related]
5. Nephritogenicity of the lprcg gene on the MRL background.
Kimura M; Ogata Y; Shimada K; Wakabayashi T; Onoda H; Katagiri T; Matsuzawa A
Immunology; 1992 Jul; 76(3):498-504. PubMed ID: 1526655
[TBL] [Abstract][Full Text] [Related]
6. High level expression of the plasma cell antigen PC.1 on the T-cell subset expanding in MRL/MpJ-lpr/lpr mice: detection with a xenogeneic monoclonal antibody and alloantisera.
Dumont FJ; Habbersett RC; Coker LZ; Nichols EA; Treffinger JA
Cell Immunol; 1985 Dec; 96(2):327-37. PubMed ID: 2943419
[TBL] [Abstract][Full Text] [Related]
7. Elevated production of interleukin 6 by hepatic MNC correlates with ICAM-1 expression on the hepatic sinusoidal endothelial cells in autoimmune MRL/lpr mice.
Ohteki T; Okamoto S; Nakamura M; Nemoto E; Kumagai K
Immunol Lett; 1993 May; 36(2):145-52. PubMed ID: 8102352
[TBL] [Abstract][Full Text] [Related]
8. Differential effect of the autoimmune Yaa and lpr genes on the acceleration of lupus-like syndrome in MRL/MpJ mice.
Merino R; Shibata T; De Kossodo S; Izui S
Eur J Immunol; 1989 Nov; 19(11):2131-7. PubMed ID: 2599002
[TBL] [Abstract][Full Text] [Related]
9. Spontaneous autoimmune skin lesions of MRL/n mice: autoimmune disease-prone genetic background in relation to Fas-defect MRL/1pr mice.
Furukawa F; Kanauchi H; Wakita H; Tokura Y; Tachibana T; Horiguchi Y; Imamura S; Ozaki S; Takigawa M
J Invest Dermatol; 1996 Jul; 107(1):95-100. PubMed ID: 8752846
[TBL] [Abstract][Full Text] [Related]
10. Hormone control of autoantibodies to calf thymus nuclear extract (CTE) and DNA in MRL-lpr and MRL-+/+ mice.
Brick JE; Walker SE; Wise KS
Clin Immunol Immunopathol; 1988 Jan; 46(1):68-81. PubMed ID: 3257179
[TBL] [Abstract][Full Text] [Related]
11. Cyclosporine therapy suppresses ocular and lacrimal gland disease in MRL/Mp-lpr/lpr mice.
Jabs DA; Lee B; Burek CL; Saboori AM; Prendergast RA
Invest Ophthalmol Vis Sci; 1996 Feb; 37(2):377-83. PubMed ID: 8603842
[TBL] [Abstract][Full Text] [Related]
12. Delineation of two defects responsible for T-cell hyporesponsiveness to concanavalin A in MRL congenic mice.
Cameron R; Waterfield JD
Immunology; 1986 Oct; 59(2):187-93. PubMed ID: 3095226
[TBL] [Abstract][Full Text] [Related]
13. A behavioral profile of autoimmune lupus-prone MRL mice.
Sakić B; Szechtman H; Keffer M; Talangbayan H; Stead R; Denburg JA
Brain Behav Immun; 1992 Sep; 6(3):265-85. PubMed ID: 1392101
[TBL] [Abstract][Full Text] [Related]
14. Selective elimination of non-lpr lymphoid cells in mice undergoing lpr-mediated graft-vs-host disease.
Perkins DL; Michaelson J; Glaser RM; Marshak-Rothstein A
J Immunol; 1987 Sep; 139(5):1406-13. PubMed ID: 2887617
[TBL] [Abstract][Full Text] [Related]
15. Cd72(c) is a modifier gene that regulates Fas(lpr)-induced autoimmune disease.
Xu M; Hou R; Sato-Hayashizaki A; Man R; Zhu C; Wakabayashi C; Hirose S; Adachi T; Tsubata T
J Immunol; 2013 Jun; 190(11):5436-45. PubMed ID: 23616572
[TBL] [Abstract][Full Text] [Related]
16. Analysis of central B cell tolerance in autoimmune-prone MRL/lpr mice bearing autoantibody transgenes.
Rubio CF; Kench J; Russell DM; Yawger R; Nemazee D
J Immunol; 1996 Jul; 157(1):65-71. PubMed ID: 8683157
[TBL] [Abstract][Full Text] [Related]
17. Behavior and immune status of MRL mice in the postweaning period.
Sakić B; Szechtman H; Talangbayan H; Denburg S; Carbotte R; Denburg JA
Brain Behav Immun; 1994 Mar; 8(1):1-13. PubMed ID: 8003767
[TBL] [Abstract][Full Text] [Related]
18. [Functional analysis of an autoantigen reactive B cell clone derived from MRL/MP-lpr/lpr mice].
Kobayashi K; Hamano T; Kakishita E
Ryumachi; 1996 Dec; 36(6):844-55. PubMed ID: 9122824
[TBL] [Abstract][Full Text] [Related]
19. Interstitial pneumonitis in autoimmune MRL/lpr mice and its treatment with cyclosporin A.
Okudaira H; Ogita T; Miyamoto T; Shiga J; Suko M; Okudaira K; Terada E; Ghoda A; Terada K; Saito M
Clin Immunol Immunopathol; 1986 Jan; 38(1):47-54. PubMed ID: 3940742
[TBL] [Abstract][Full Text] [Related]
20. Hepatic reticuloendothelial system activation in autoimmune mice: differences between (NZB X NZW)F1 and MRL-lpr/lpr strains.
Magilavy DB; Hundley TR; Steinberg AD; Katona IM
Clin Immunol Immunopathol; 1987 Mar; 42(3):386-98. PubMed ID: 3030589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
